Navigation Links
Consumer and manufacturing groups back bill to protect US drug supply
Date:8/3/2010

The Pew Prescription Project, joined by major consumer, physician and chemical manufacturer groups, today announced support for a new bill that would give the U.S. Food and Drug Administration (FDA) much-needed authorities to better protect pharmaceutical supply chains. The organizations made the announcement in a joint letter to Congress and during an audio news conference with Senator Michael Bennet (D-CO), who will introduce this drug safety legislation.

Consumers face a surge in drug recalls, with a 400 percent increase in 2009 compared with the previous year. This year, the trend has continued with the high-profile voluntary recall of over 130 million bottles of over-the-counter children's drugs.

To boost consumer protections against adulterated drugs, the proposed legislation would establish quality standards for the FDA, drug companies and their contractors, who are increasingly based overseas, where safeguards may be lower than in the U.S. The legislation also would improve the federal government's tracking systems of manufacturing sites. The FDA has recently signaled it will strengthen inspection and quality requirements for drug makers who outsource to suppliers and suggested the agency should have the authority, currently lacking, to require a company to recall drugs that have been found to be contaminated or unsafe.

In the wake of more than 100 U.S. deaths associated with contaminated heparin from China, Americans' trust in imported drugs has been badly shaken. A survey commissioned this spring by the Pew Prescription Project found an overwhelming majority of Americans94 percentsupport giving the FDA authority to recall drugs when they are found unsafe or contaminated. This poll of likely voters found that 70 percent of respondents have little or no confidence that drugs manufactured in China are free from contamination and safe for Americans and 54 percent expressed the same concern about drugs manufactured in India. The bipartisan polling was conducted by Hart Research Associates and Public Opinion Strategies.

"According to our polling, most Americans lack confidence that drugs made in India and China today are safe," said Allan Coukell, director of the Pew Prescription Project. "The Drug Safety and Accountability Act takes needed steps toward rebuilding that trust by giving the FDA new authorities to recall drugs and establishing some important safeguards to ensure the quality and safety of drugs and drug ingredients."

"This bill is a critical step toward improving the safety of the prescription drugs millions of Americans depend on every day," said David Sloane, AARP senior vice president. "It gives the FDA the necessary authority to ensure strong quality standards protecting U.S. consumers are upheld in the U.S. and around the world, and encourages the rapid sharing of information to help quickly identify and act on quality control issues."

"Physicians support strong efforts to ensure that the drugs they prescribe to their patients are safe and effective," said J. Fred Ralston, Jr., MD, FACP, president of the American College of Physicians. "This legislation is an important step toward safeguarding the nation's drug supply by improving quality standards and strengthening the FDA's ability to track the domestic and foreign drug supply."

Brant Zell, chairman of the Society of Chemical Manufacturers of America (SOCMA) Bulk Pharmaceutical Task Force, said, "Our members strongly endorse legislation that strengthens the FDA and increases public safety and health with a more secure drug supply. We believe this legislation is a good starting point. Today, about 80 percent of the drugs' active ingredients come from overseas in countries like India and China. However, imported drugs receive less than 5 percent of FDA's resources. Senator Bennet's bill will give the FDA more authority, tools and resources to help ensure a safe U.S. drug supply."

"This bill gives us important new protections against contamination of the drugs Americans depend on every day," said Marcia Hams, director of Prescription Access and Quality at Community Catalyst, a national consumer health organization. "With more drug manufacturing outsourced to other countries with weak oversight, the FDA must be able to set strong standards and enforce them through recalls of defective drugs and penalties."

"We hope that this legislation can be approved in the remaining days of this Congressbefore consumers are again faced with another Chinese-heparin-type case of death and injury from unsafe, contaminated and corrupted drugs," said William Vaughan, health policy analyst at Consumers Union.


'/>"/>

Contact: Linda Paris
lparis@pewtrusts.org
202-540-6354
Pew Health Group
Source:Eurekalert

Related medicine news :

1. Suite 101.com Provides Insight Into Consumer Reading Behavior Online
2. AchooAllergy.com Adds Allergist Interviews to Monthly Allergy Consumer Report Newsletter
3. Aesthetic Society Launches Project Beauty, NEW Consumer Website Covering All Things Beauty
4. Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children
5. Online Broker Lets Consumers Choose The Price of Life Insurance
6. The Time is Now to Capitalize on Today's Direct-to-Consumer Health Insurance Opportunity via the Exchange Marketplace
7. Better Hearing Institute Publishes Comprehensive Consumer Guide to Buying Hearing Aids
8. Older Chinese consumers perceive themselves younger than actual age
9. IADR and GSK Consumer Healthcare announce winners of 2010 Innovation in Oral Care Awards
10. Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians
11. Are Fish Oil Supplements a Waste of Money? Healthy-Oil-Planet.com Helps Consumers Make Informed Decisions on Nutritional Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... “The Saint ... Saint with Trin, and Omega Station” is the creation of published author, Chris Jackson. ... Dallas Metroplex where he works in the Dallas Independent School District teaching English. He ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a pre-clinical stage ... the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna ... advances towards regulatory and clinical phases. , "This is another important step for ...
(Date:4/22/2017)... ... April 22, 2017 , ... Ecommerce sales have grown every year since ... $394.9 billion. The consequences of rapid innovation and growth are often neglected in ... it is every business and individual’s job to give something back to the planet ...
(Date:4/22/2017)... ... ... San Juan Capistrano summer camp team at the Boys and Girls Club of ... to provide physical activities for all campers. To read the report, click here ... increase in specialty camps that focus on what the report terms as “sitting subjects” like ...
(Date:4/21/2017)... Boston, MA (PRWEB) , ... April 21, 2017 ... ... Boston University professor Christopher Salas-Wright finds that youth violence is declining—and at noteworthy ... in the relative proportion of young people involved in violence in the United ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt ... the first patients in Nashville , ... the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) ... designed to provide long-term reflux control by restoring normal ... affects nearly 65 million people in the ...
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... , April 18, 2017 Research and ... Market 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a ... report, Global Arthroscopy Devices Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Medicine Technology: